The recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran: comment.
J Thromb Haemost
; 15(9): 1882-1883, 2017 09.
Article
in En
| MEDLINE
| ID: mdl-28585328
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antibodies, Monoclonal, Humanized
/
Dabigatran
Language:
En
Journal:
J Thromb Haemost
Journal subject:
HEMATOLOGIA
Year:
2017
Document type:
Article
Affiliation country:
Italy